Towards a burden of disease research agenda
Disability-Adjusted Life Years (DALY) have become a common metric for assessing the combined effects of morbidity and mortality. However, the lack of resources and/or input data, combined with the complexity of the methodological framework, resulted in major disparities in research capacity and knowledge about burden of disease estimations across Europe. Since 2019, the European Burden of Disease (burden-eu) Network has been acting as a technical platform for strengthening capacity in burden of disease assessments. The burden-eu network developed a forward-looking research agenda, identifying four key burden of disease themes: transparency and availability, method refinement, potential expansions, and specific topics. The research agenda's priorities can be used to prioritise and guide the design of studies in the burden of disease framework.
Authors
- Elena von der Lippe (ORCID: https://orcid.org/0000-0003-3757-1264)
- Periklis Charalampous (ORCID: https://orcid.org/0000-0002-3460-4828)
- Brecht Devleesschauwer (ORCID: https://orcid.org/0000-0002-2867-6892)
- Milena Santric MİLİCEVİC
- Henk Hilderink (ORCID: https://orcid.org/0000-0001-7181-8553)
- Ricardo Assunção
- Dietrich Plass
- Sara M. Pires
- Juanita Haagsma
- Grant Wyper
- Vanessa Gorasso
Institutions
- Robert Koch Institute (DE)
- Erasmus MC (NL)
- Escola Superior de Saúde Egas Moniz (PT)
- Ghent University (BE)
- University of Belgrade (RS)
- National Institute for Public Health and the Environment (NL)
- Center for Health, Exercise and Sport Sciences (RS)
- Public Health Scotland (GB)
- German Environment Agency (DE)
- National Institute of Health Dr. Ricardo Jorge (PT)
- Sciensano (Belgium) (BE)
- University of Glasgow (GB)
- UCLouvain (BE)
- Technical University of Denmark (DK)
Publication Details
- Journal
- Population Health Metrics
- Published
- 2026-03-26
- DOI
- https://doi.org/10.1186/s12963-026-00467-4
- Primary Topic
- Chronic Disease Management Strategies
- Type
- article
- Field-Weighted Citation Impact
- 0.00